DARIFIX-7.5 Tablet
Darifenacin Prolonged Release Tablet – PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
| Composition | Darifenacin Hydrobromide eq. to Darifenacin 7.5 mg (prolonged release) |
|---|---|
| Dosage Form | Prolonged Release Tablet |
| Pack Type | Alu-Alu |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 3500 |
| Therapy | Urology – Overactive bladder — Antimuscarinic (M3-selective) |
| Storage | Store below 30 °C in a dry place, protected from light. Keep out of reach of children. |
📱 WhatsApp Enquiry📞 Call: +919041677932
For chemists, distributors and doctors: DARIFIX-7.5 (darifenacin 7.5 mg PR tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About DARIFIX-7.5 Tablet
DARIFIX-7.5 is Trumac Healthcare’s darifenacin prolonged release tablet IP 7.5 mg, packed 10 x 10 in Alu-Alu (MRP ₹3,500) and made for Trumac at WHO-GMP certified partner units.
Darifenacin is a once-daily, bladder-selective (M3) antimuscarinic used by urologists and gynaecologists for overactive bladder. Its selectivity means less effect on memory and heart rate than older drugs, which suits elderly patients.
It complements OXYBLIZ (oxybutynin) and BETHOCAM (bethanechol) in Trumac’s urology range.
Indications
- Overactive bladder – urgency, frequency and urge incontinence
Mechanism of Action
Darifenacin selectively blocks muscarinic M3 receptors, which drive contraction of the bladder detrusor muscle. This reduces involuntary bladder contractions, increases bladder capacity and lessens urgency and leakage.
Dosage & Administration
One 7.5 mg tablet once a day, swallowed whole with water, with or without food; do not chew or crush. After 2 weeks the doctor may increase to 15 mg once a day. The dose stays at 7.5 mg with moderate liver impairment or with moderate CYP3A4 inhibitors.
Side Effects
Dry mouth and constipation are the most common; also headache, indigestion, nausea, dry eyes and blurred vision. Rarely urinary retention, dizziness or allergic reactions. It can reduce sweating in hot weather.
Contraindications & Precautions
Do not use with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, myasthenia gravis, severe liver impairment, severe ulcerative colitis or toxic megacolon, or with strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir). Use with care in bladder outflow obstruction, reflux and constipation.
Storage
Store below 30 °C in a dry place, protected from light. Keep out of reach of children.
DARIFIX-7.5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Also for bladder problems: OXYBLIZ (oxybutynin) · BETHOCAM (bethanechol).
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the urology products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare urology PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Frequently Asked Questions
Who supplies darifenacin tablets for PCD franchise?
DARIFIX-7.5 is made for Trumac Healthcare at WHO-GMP certified partner units and offered on a PCD pharma franchise with monopoly rights for your district. No franchise fee; first order from ₹25,000.
Can distributors buy DARIFIX-7.5 on wholesale?
Yes. Licensed distributors, wholesalers and chemists can buy it in bulk – message us on WhatsApp for net rates. Orders are usually dispatched within 48 hours of confirmation.
Is darifenacin available for third party manufacturing?
Trumac has no plant of its own; its products are made at WHO-GMP certified partner units. For your own brand, share the quantity and label details and we will tell you what is possible.
What is the pack and MRP of DARIFIX-7.5?
10 x 10 prolonged release tablets in Alu-Alu packs, MRP ₹3,500 as per the current product list.
